4Gilks CB, Young RH, Aguine P, et al. Adenoma malignum(minimal deviation adenocarcinoma) of the uterine cervix: a Clinicopathologic and immumohistochemical. Analysis of 26 eases. Am J Clin Pstol, 1989,13:717.
5Hart, William R. Symposium part Ⅱ: Special types of adenocarcinoma of the uterine cervix. International Journal of Gynecological Pathology, 2002,21(40):327.
6Hirai Y, Takeshima N, Hanga A, et al. Clinicocytopathologic study of adenoma malignum of the uterine cervix. Gynecol Oncol, 1998,70(2):219.
7Nucci M R, Lee K R, Crum C P. Tumors of the female genital tract (PART E: Cervix). In:Fletcher C D M (ed) Diagnostic histopathology of tumors [ M ]. 3ed, New York: Churchill Livingstone. 2007 : 697-718.
8Mikami Y, Kiyokawa T, Moriya T, et al, Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma (' adenoma malignum' ) and endoeervical glandular hyperplasia: a study using oestrogen receptor and alphasmooth muscle actin double immunostaining [ J ]. Histopathology, 2005,46(2) : 130-136.
9Hayashi I, Tsuda H, Shimoda T. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of tbe cervix [J]. Am J Surg Pathol, 2000,24 (4) : 559-562.
10Iehimura T, Koizumi T, Tateiwa H, et al. Immunohistochemical expression of gastric muein and p53 in minimal deviation adenocarcinoma of the uterine cervix [J]. Int J Gynecol Pathol, 2001,20 (3) : 220- 226.
